HOME >> MEDICINE >> NEWS
Asthma home intervention cost-effective for inner-city children, research reveals

CHAPEL HILL Through efforts to limit exposure to environmental irritants, health workers and municipalities can cut illness generally among inner-city children with asthma and also the number of clinic visits for those young patients by at least 19 percent, a new study concludes. The cost can be as low as $1,469 per affected family.

Last year, researchers reported in the New England Journal of Medicine that an intervention designed to reduce exposures of children with asthma to irritants and allergens at home succeeded in partially curtailing disruptive and sometimes life-threatening symptoms.

The latest part of the multi-center study evaluated the cost-effectiveness of those home-based efforts, which included buying impermeable mattress and pillow covers for each child. It showed that the statistically significant reductions in sickness and associated health-care use substantially offset the intervention's cost.

Expenses arose from administering an allergy skin test, hiring and training high school graduates as environmental counselors, buying air filters and vacuum cleaners and engaging pest management services when needed. Vacuum cleaners served to effectively remove cockroach droppings, dust mites, animal dander and other dirt that can trigger asthma attacks in susceptible people.

The cost per symptom-free day for each child was $25.57, investigators found. Asthmatic children in the study used 13 percent fewer B-agonist inhalers for relieving symptoms over the two-year study.

Dr. Meyer Kattan of Mount Sinai School of Medicine, Dr. Sally Stearns of the University of North Carolina at Chapel Hill School of Public Health and colleagues conducted the study. A report on their work appears in the current issue of the Journal of Allergy and Clinical Immunology.

"We demonstrated that a comprehensive home-based environmental intervention that was tailored to the child's exposures resulted in decreased symptoms and unschedu
'"/>

Contact: David Williamson
rdtokids@email.unc.edu
919-962-8596
University of North Carolina at Chapel Hill
25-Oct-2005


Page: 1 2

Related medicine news :

1. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
2. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
3. Asthma study shows patients have more options to control disease
4. Asthma linked to soot from diesel trucks in Bronx
5. Asthma risk increased in women with high levels of fat tissue inflammatory protein
6. Asthmatic children in multi-family housing hit by indoor nitrogen dioxide
7. Asthma inhalers adopted more slowly for minority patients and children
8. Asthma patients report better asthma control when seeing an allergist
9. Asthma research sounds warning for older Australians
10. Asthma drug fluticasone works as well as other drugs at half the dose
11. Asthmatics naturally deficient in antiviral immunity, report scientists

Post Your Comments:
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 ... transplantation is nothing new. The first kidney transplant took ... 1963 and the first human heart transplant in 1967. By ... entire face. One major organ still eludes the transplant ... of U.S. scientists has its way, that dream may become ...
(Date:10/31/2014)... News) -- The number of medical malpractice payments in ... to a new study. And compensation payment amounts ... or declined in recent years, researchers report online Oct. ... Association . "For many physicians, the prospect of ... of modern clinical practice," researchers, led by Michelle Mello, ...
(Date:10/31/2014)... WASHINGTON, DC (October 31, 2014) — A new ... (Milken Institute SPH) at the George Washington University ... for pregnant women who are enrolled in Covered ... which includes the Comprehensive Perinatal Services Program (CPSP). ... the nation,s most successful programs ever developed for ...
(Date:10/30/2014)... day provide new treatments for injuries and damage to ... Cartilage, for example, is a hard material that caps ... smoothly. UC Davis biomedical engineers, exploring ways to toughen ... the body, report new developments this week in the ... . , "The problem with engineered tissue is that ...
(Date:10/30/2014)... group at the DFG Research Center for Regenerative Therapies ... (CRTD) demonstrated for the first time the in vitro ... dimensions from mouse embryonic stem cells. Correct spatial organization ... dorsal/ventral axis was observed., This study has been published ... Reports " on 30.10.2014 ., For many years Elly ...
Breaking Medicine News(10 mins):Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3Health News:Fewer Malpractice Claims Paid in U.S. 2Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Making lab-grown tissues stronger 2Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2
(Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
(Date:10/30/2014)... , Oct. 30, 2014 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... to release third quarter 2014 financial results on Wednesday, ... The Company,s management will hold a conference call ... 2014, which is 8:30 p.m., Beijing Time on November ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3China Biologic to Report Third Quarter 2014 Financial Results 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
Cached News: